| DAA651 |
Bone porosity increases |
Physiological |
bone |
Human |
— |
— |
|
| DAA645 |
Bone remodeling decreases |
Physiological |
bone |
Human |
— |
— |
|
| DAA647 |
Bone resorption increases for cortical bone |
Physiological |
bone |
Human |
— |
— |
|
| DAA1852 |
brain derived neurotrophic factor |
Molecular |
skeletal muscle |
Mouse |
Bdnf |
5.0% Increase Gene Expression Level |
|
| DAA541 |
brain protein 44-like |
Molecular |
skeletal muscle |
Human |
BRP44L |
5.0% Decrease Gene Expression Level |
|
| DAA1738 |
bromodomain PHD finger transcription factor |
Molecular |
muscle |
Mouse |
Bptf |
3.0% Increase Gene Expression Level |
|
| DAA453 |
butyrophilin-like 3 |
Molecular |
skeletal muscle |
Human |
BTNL3 |
5.0% Decrease Gene Expression Level |
|
| DAA419 |
cadherin 5, type 2 (vascular endothelium) |
Molecular |
skeletal muscle |
Human |
CDH5 |
6.0% Decrease Gene Expression Level |
|
| DAA665 |
Calcification makes cartilage more brittle |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA663 |
Calcification of cartilage matrix |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA801 |
Calcification of costal cartilage |
Physiological |
thorax, cartilage |
Human |
— |
— |
|
| DAA1737 |
calcium/calmodulin-dependent protein kinase II, beta |
Molecular |
muscle |
Mouse |
Camk2b |
7.0% Increase Gene Expression Level |
|
| DAA443 |
carbonic anhydrase IV |
Molecular |
skeletal muscle |
Human |
CA4 |
6.0% Decrease Gene Expression Level |
|
| DAA1752 |
cardiotrophin 1 |
Molecular |
muscle |
Mouse |
Ctf1 |
4.0% Increase Gene Expression Level |
|
| DAA666 |
Cartilage asbestos transformation |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA664 |
Cartilage calcification interferes with normal diffusion metabolism |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA658 |
Cartilage color changes |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA660 |
Cartilage joint surface cracks and frays |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA667 |
Cartilage matrix softening and cavity formation |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA661 |
Cartilage matrix synthesis to degradation ratio decreases |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA671 |
Cartilage resiliency decreases |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA1740 |
cation channel, sperm associated 1 |
Molecular |
muscle |
Mouse |
Catsper1 |
10.0% Decrease Gene Expression Level |
|
| DAA346 |
CCAAT/enhancer binding protein (C/EBP), alpha |
Molecular |
skeletal muscle |
Human |
CEBPA |
28.0% Increase Gene Expression Level |
|
| DAA529 |
CCAAT/enhancer binding protein (C/EBP), beta |
Molecular |
skeletal muscle |
Human |
CEBPB |
3.0% Increase Gene Expression Level |
|
| DAA1747 |
CCR4-NOT transcription complex, subunit 8 |
Molecular |
muscle |
Mouse |
Cnot8 |
3.0% Decrease Gene Expression Level |
|